Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18255160 | 1.00 | GBA1 (0.42) | GBA1MAN1B1 | |
| SCHEMBL18663507 | 1.00 | GBA1 (0.42) | GBA1MAN1B1 | |
| SCHEMBL18663731 | 1.00 | GBA1 (0.42) | GBA1MAN1B1 | |
| SCHEMBL12778997 | 1.00 | GBA1 (0.42) | GBA1MAN1B1 | |
| SCHEMBL23583924 | 0.84 | GBA1 (0.34) | GBA1MAN1B1 | |
| SCHEMBL18663800 | 0.84 | GBA1 (0.34) | GBA1MAN1B1 | |
| SCHEMBL18663513 | 0.84 | GBA1 (0.34) | GBA1MAN1B1 | |
| SCHEMBL21188583 | 0.84 | GBA1 (0.34) | GBA1MAN1B1 | |
| SCHEMBL19079554 | 0.84 | GBA1 (0.34) | GBA1MAN1B1 | |
| SCHEMBL19079552 | 0.84 | GBA1 (0.34) | GBA1MAN1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421724-B2 | Compositions for preventing and/or treating degenerative disorders of the central nervous system | AMICUS THERAPEUTICS, INC. (US) | 2019-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10421724-B2 | Compositions for preventing and/or treating degenerative disorders of the central nervous system | PMP22, GAP43, CHAT | GBA1 306/4885MAN1B1 2166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.